AIP vs BIO · rev $57.7M vs rev $2.58B
Arteris Inc (AIP) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
Arteris Inc (AIP) is a semiconductors company listed on US.
BIO (BIO) common stock.
Latest reported AIP revenue for 2024-12-31 was $57.7M. Net income was -$33.6M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. AIP currently screens at market cap $387.0M.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
AIP currently screens at market cap $387.0M. BIO currently screens at market cap $0.
Not investment advice. Open the AIP and BIO stock pages for the full models.
Not investment advice.